180 related articles for article (PubMed ID: 33119591)
21. Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.
Tucker A; Tembo T; Tampi RP; Mutale J; Mukumba-Mwenechanya M; Sharma A; Dowdy DW; Moore CB; Geng E; Holmes CB; Sikazwe I; Sohn H
J Int AIDS Soc; 2020 Feb; 23(2):e25431. PubMed ID: 32064766
[TBL] [Abstract][Full Text] [Related]
22. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
[TBL] [Abstract][Full Text] [Related]
23. Understanding the variation in costs among HIV primary care providers.
Gilman BH; Green JC
AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
[TBL] [Abstract][Full Text] [Related]
24. Patient and health provider costs of integrated HIV, diabetes and hypertension ambulatory health services in low-income settings - an empirical socio-economic cohort study in Tanzania and Uganda.
Shiri T; Birungi J; Garrib AV; Kivuyo SL; Namakoola I; Mghamba J; Musinguzi J; Kimaro G; Mutungi G; Nyirenda MJ; Okebe J; Ramaiya K; Bachmann M; Sewankambo NK; Mfinanga S; Jaffar S; Niessen LW
BMC Med; 2021 Sep; 19(1):230. PubMed ID: 34503496
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries.
Cerecero-García D; Pineda-Antunez C; Alexander L; Cameron D; Martinez-Silva G; Obure CD; Marseille E; Vu L; Kahn JG; Vassall A; Gomez G; Bollinger L; Levin C; Bautista-Arredondo S
Afr J AIDS Res; 2019 Dec; 18(4):297-305. PubMed ID: 31779577
[No Abstract] [Full Text] [Related]
26. Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia.
Bautista-Arredondo S; Sosa-Rubi SG; Opuni M; Contreras-Loya D; La Hera-Fuentes G; Kwan A; Chaumont C; Chompolola A; Condo J; Dzekedzeke K; Galarraga O; Martinson N; Masiye F; Nsanzimana S; Wamai R; Wang'ombe J;
PLoS One; 2018; 13(9):e0203121. PubMed ID: 30212497
[TBL] [Abstract][Full Text] [Related]
27. Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.
Gerlach J; Sequeira M; Alvarado V; Cerpas C; Balmaseda A; Gonzalez A; de Los Santos T; Levin CE; Amador JJ; Domingo GJ
J Int AIDS Soc; 2010 Nov; 13():43. PubMed ID: 21054866
[TBL] [Abstract][Full Text] [Related]
28. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
30. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
[TBL] [Abstract][Full Text] [Related]
31. Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting.
Zegeye EA; Mbonigaba J; Kaye S; Johns B
BMC Health Serv Res; 2019 Mar; 19(1):148. PubMed ID: 30841870
[TBL] [Abstract][Full Text] [Related]
32. Cost implications of HIV retesting for verification in Africa.
Lasry A; Kalou MB; Young PR; Rurangirwa J; Parekh B; Behel S
PLoS One; 2019; 14(7):e0218936. PubMed ID: 31260467
[TBL] [Abstract][Full Text] [Related]
33. The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.
Obure CD; Sweeney S; Darsamo V; Michaels-Igbokwe C; Guinness L; Terris-Prestholt F; Muketo E; Nhlabatsi Z; ; Warren CE; Mayhew S; Watts C; Vassall A
PLoS One; 2015; 10(5):e0124476. PubMed ID: 25933414
[TBL] [Abstract][Full Text] [Related]
34. Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.
Bautista-Arredondo S; Colchero MA; Amanze OO; La Hera-Fuentes G; Silverman-Retana O; Contreras-Loya D; Ashefor GA; Ogungbemi KM
PLoS One; 2018; 13(5):e0194305. PubMed ID: 29718906
[TBL] [Abstract][Full Text] [Related]
35. Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe.
Mwenge L; Sande L; Mangenah C; Ahmed N; Kanema S; d'Elbée M; Sibanda E; Kalua T; Ncube G; Johnson CC; Hatzold K; Cowan FM; Corbett EL; Ayles H; Maheswaran H; Terris-Prestholt F
PLoS One; 2017; 12(10):e0185740. PubMed ID: 29036171
[TBL] [Abstract][Full Text] [Related]
36. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda.
Guthrie T; Muheki C; Rosen S; Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebela N; Long LC
BMC Health Serv Res; 2022 Nov; 22(1):1315. PubMed ID: 36329450
[TBL] [Abstract][Full Text] [Related]
37. Layering and scaling up chronic non-communicable disease care on existing HIV care systems and acute care settings in Kenya: a cost and budget impact analysis.
Osetinsky B; Mwangi A; Pastakia S; Wilson-Barthes M; Kimetto J; Rono K; Laktabai J; Galárraga O
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25496. PubMed ID: 32562355
[TBL] [Abstract][Full Text] [Related]
38. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
